TDAY:NYSEUSA TODAY Co., Inc. Analysis
Data as of 2026-05-04 - not real-time
$6.88
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
USA TODAY Co. (TDAY) trades below its short‑term moving averages despite a technically bullish alignment of longer‑term SMAs, indicating a near‑term pullback risk. The stock’s price sits close to a identified support level while volume has been trending lower, and the MACD histogram is negative, suggesting short‑term downside pressure. Fundamentally, the company faces headwinds: revenue is contracting, profit margins are thin, and leverage is extremely high, with debt dwarfing equity.
On the valuation side, the price‑to‑earnings multiple is markedly above the industry average and the discounted cash flow model implies a fair value far below the current market price, pointing to significant overvaluation. Nonetheless, analyst sentiment remains positive, with a consensus “buy” rating and a market environment characterized by extreme greed, which may be fueling the price despite the underlying challenges.
On the valuation side, the price‑to‑earnings multiple is markedly above the industry average and the discounted cash flow model implies a fair value far below the current market price, pointing to significant overvaluation. Nonetheless, analyst sentiment remains positive, with a consensus “buy” rating and a market environment characterized by extreme greed, which may be fueling the price despite the underlying challenges.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- negative MACD momentum
- decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- bullish alignment of longer‑term SMAs
- analyst consensus buy rating
- potential upside from digital marketing initiatives
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- persistent revenue decline and high debt load
- valuation gap between market price and DCF fair value
- industry transition to digital platforms
Key Metrics & Analysis
Financial Health
Revenue Growth-4.00%
Profit Margin1.27%
P/E Ratio38.2
ROE19.91%
ROA4.69%
Debt/Equity800.37
P/B Ratio6.5
Op. Cash Flow$110.4M
Free Cash Flow$102.7M
Industry P/E18.9
Technical Analysis
TrendBullish
RSI44.3
Support$6.58
Resistance$7.68
MA 20$7.19
MA 50$6.77
MA 200$5.26
MACDBearish
VolumeDecreasing
Fear & Greed Index87.73
Valuation
Fair Value$2.19
Target Price$8.21
Upside/Downside19.39%
GradeOvervalued
TypeValue
Risk Assessment
Beta0.67
Volatility35.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.